← Browse by Condition
Medical Condition
cognitive decline
Total Trials
12
Recruiting Now
12
Trial Phases
Phase 2
ClinicalMetric tracks all active clinical trials for cognitive decline sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — cognitive decline Clinical Trials
How many clinical trials are currently recruiting for cognitive decline?
ClinicalMetric currently tracks 12 actively recruiting clinical trials for cognitive decline, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 12. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for cognitive decline?
cognitive decline research spans Phase 2 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a cognitive decline clinical trial?
Eligibility criteria for cognitive decline trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2 2
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT07804498 Phase 2
Recruiting
Enrollment
122 pts
Location
Italy
Sponsor
University of Milano Bicocca
NCT03657745
Recruiting
Enrollment
2,000 pts
Location
United States
Sponsor
Alzheimer's Light LLC
NCT07207993
Recruiting
Enrollment
64 pts
Location
United States
Sponsor
The University of Tennessee, K...
NCT06703320
Recruiting
Enrollment
60 pts
Location
China
Sponsor
Dingqun Bai
NCT03954899
Recruiting
Enrollment
230 pts
Location
United States
Sponsor
Natalie Denburg
NCT05922137
Recruiting
Enrollment
120 pts
Location
China
Sponsor
Second Affiliated Hospital, Zh...
NCT06727773 Phase 2
Recruiting
Enrollment
90 pts
Location
United States
Sponsor
UNC Lineberger Comprehensive C...
NCT05106036
Recruiting
Enrollment
4,000 pts
Location
United States
Sponsor
University of Texas Southweste...
NCT06507254
Recruiting
Enrollment
300 pts
Location
United States
Sponsor
University of California, Los ...
NCT05088187
Recruiting
Enrollment
320 pts
Location
Sweden
Sponsor
Karolinska University Hospital
NCT07242495
Recruiting
Enrollment
34 pts
Location
Pakistan
Sponsor
Foundation University Islamaba...
NCT06730711
Recruiting
Enrollment
600 pts
Location
China
Sponsor
First Affiliated Hospital of C...
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology